대한부인종양학회

최신 논문

총 게시글 : 33

A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancer 2025-12-19 VIEW : 5
Pilot Study of Daily Exemestane in Women with Endometrial Intraepithelial Neoplasia or Low-Grade Endometrial Cancer 2025-12-19 VIEW : 3
Prognostic role of immunohistochemical and molecular markers in no specific molecular profile endometrial cancer: a systematic review and meta-analysis 2025-12-19 VIEW : 4
Nivolumab and Ipilimumab Combination Treatment in Advanced Ovarian and Endometrial Clear Cell Cancers: A Nonrandomized Clinical Trial 2025-12-19 VIEW : 1
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial 2025-12-19 VIEW : 3
Lymphadenectomy or sentinel node biopsy for the management of endometrial cancer. 2025-09-26 VIEW : 37
Fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer. 2025-09-26 VIEW : 16
The challenge of molecular stratification in No Specific Molecular Profile endometrial cancer. 2025-09-26 VIEW : 9
Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial. 2025-09-26 VIEW : 5
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial 2025-09-26 VIEW : 5
Robotic-assisted versus conventional laparoscopic surgery for endometrial cancer: long-term results of a randomized controlled trial. 2025-06-23 VIEW : 47
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial. 2025-06-23 VIEW : 15
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma. 2025-06-23 VIEW : 12
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial. 2025-06-23 VIEW : 9
A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study. 2025-06-23 VIEW : 5

1
2
3